Dexin Services Plans Major Connected Capital Increase in Key Subsidiary

Dexin Services Group Ltd. ( (HK:2215) ) has shared an announcement.

Dexin Services Group Limited has disclosed that in September 2025 an investor, Deqing Kaisibo, injected RMB10.3 million into an indirect subsidiary, subscribing for about 4.9% of its enlarged equity and reducing the group’s interest in that entity to roughly 95.1%. This prior capital increase qualified as a discloseable transaction under Hong Kong Listing Rules, triggering reporting and announcement obligations due to the level of percentage ratios involved.

The company has now entered into a further capital increase agreement under which Deqing Kaisibo will contribute about RMB96.9 million for a 30.0% stake in the enlarged equity of the same subsidiary, ultimately holding around 34.9% while the group’s interest falls to about 65.1%. Because Deqing Kaisibo is controlled by executive directors, the deal is both a major disposal and a non-exempt connected transaction, requiring shareholder and independent shareholder approval at an extraordinary general meeting, with interested director Tang Junjie abstaining from voting.

The most recent analyst rating on (HK:2215) stock is a Sell with a HK$0.26 price target. To see the full list of analyst forecasts on Dexin Services Group Ltd. stock, see the HK:2215 Stock Forecast page.

More about Dexin Services Group Ltd.

Dexin Services Group Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating through indirect non-wholly owned subsidiaries, including Shengquan Technology and Zhida Xiaorui. The group holds controlling interests in a target company in which it is adjusting its equity stake via capital increases involving an external investor.

Average Trading Volume: 77,468

Technical Sentiment Signal: Sell

Current Market Cap: HK$243.2M

For a thorough assessment of 2215 stock, go to TipRanks’ Stock Analysis page.